BioNTech Return On Capital Employed from 2010 to 2025

BNTX Stock  USD 114.00  3.03  2.73%   
BioNTech Return On Capital Employed yearly trend continues to be fairly stable with very little volatility. Return On Capital Employed will likely drop to 0.03 in 2025. During the period from 2010 to 2025, BioNTech Return On Capital Employed regression line of annual values had significance of  0.03 and arithmetic mean of (0.05). View All Fundamentals
 
Return On Capital Employed  
First Reported
2010-12-31
Previous Quarter
0.0297
Current Value
0.0282
Quarterly Volatility
0.41778362
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioNTech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioNTech's main balance sheet or income statement drivers, such as Tax Provision of 279.5 M, Net Interest Income of 422.3 M or Interest Income of 431.8 M, as well as many indicators such as Price To Sales Ratio of 6.54, Dividend Yield of 0.011 or PTB Ratio of 1.07. BioNTech financial statements analysis is a perfect complement when working with BioNTech Valuation or Volatility modules.
  
Check out the analysis of BioNTech Correlation against competitors.

Latest BioNTech's Return On Capital Employed Growth Pattern

Below is the plot of the Return On Capital Employed of BioNTech SE over the last few years. It is BioNTech's Return On Capital Employed historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioNTech's overall financial position and show how it may be relating to other accounts over time.
Return On Capital Employed10 Years Trend
Slightly volatile
   Return On Capital Employed   
       Timeline  

BioNTech Return On Capital Employed Regression Statistics

Arithmetic Mean(0.05)
Coefficient Of Variation(899.81)
Mean Deviation0.27
Median(0.28)
Standard Deviation0.42
Sample Variance0.17
Range1.5211
R-Value0.54
Mean Square Error0.13
R-Squared0.29
Significance0.03
Slope0.05
Total Sum of Squares2.62

BioNTech Return On Capital Employed History

2025 0.0282
2024 0.0297
2023 0.033
2022 0.62
2021 1.24
2020 -0.0481

About BioNTech Financial Statements

BioNTech investors use historical fundamental indicators, such as BioNTech's Return On Capital Employed, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in BioNTech. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Return On Capital Employed 0.03  0.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for BioNTech Stock Analysis

When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.